It has long been observed that early genetic events of thyroid cancer progression (e.g., BRAF mutations) are frequently found in patients with both well-differentiated thyroid cancer and poorly differentiated or anaplastic thyroid cancer because they are involved in the initiation of tumor development. This evidence concerns the gene BRAF and neoplasm.